COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
K FaksovaD WalshY JiangJ GriffinA PhillipsA GentileJ C KwongK MacartneyM NausZ GrangeS EscolanoG SepulvedaA ShettyA PillsburyC SullivanZ NaveedN Z JanjuaN GiglioJ PeräläS NasreenH GiddingP HoviT VoF CuiL DengL CullenM ArtamaH LuH J ClothierK BattyJ PaynterH Petousis-HarrisJ ButteryS BlackA HviidPublished in: Vaccine (2024)
This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.